Ocular melanoma in a patient successfully treated for diffuse malignant peritoneal mesothelioma: a case report

被引:0
作者
Langlais, Sara [1 ]
Velazquez-Martin, Juan Pablo [2 ]
Dube, Pierre [1 ]
Simpson, Ernest Rand [2 ]
Leblanc, Guy [1 ]
Sideris, Lucas [1 ]
机构
[1] Univ Montreal, Dept Surg, Hop Maisonneuve Rosemont, Montreal, PQ H1T 2M4, Canada
[2] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5G 2M9, Canada
来源
WORLD JOURNAL OF SURGICAL ONCOLOGY | 2012年 / 10卷
关键词
BAP1; Diffuse malignant peritoneal mesothelioma; Ocular melanoma; BAP1; MANAGEMENT; MUTATIONS;
D O I
10.1186/1477-7819-10-90
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Diffuse malignant peritoneal mesothelioma and ocular melanoma are both rare tumors. To the best of our knowledge there is only one previous report of three cases in a family with known susceptibility to malignancies associating diffuse malignant peritoneal mesothelioma and ocular melanoma, with no sporadic cases previously reported. Case presentation: We describe the case of a 59-year-old man with a history of diffuse malignant peritoneal mesothelioma, who presented with ocular melanoma 41 months after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. We also briefly review the literature. Conclusions: Diffuse malignant peritoneal mesothelioma is an uncommon but aggressive disease. As diffuse malignant peritoneal mesothelioma characteristically remains confined to the abdominal cavity, any new extra-abdominal symptom should eventually raise suspicion of another primary tumor. Few cases of diffuse malignant peritoneal mesothelioma associated with other primary tumors have been reported. As ocular melanoma is also infrequent, we suspect a genetic predisposition to these tumors. There is emerging evidence supporting the role of BAP1 mutations in the pathogenesis of these two neoplasias.
引用
收藏
页数:4
相关论文
共 15 条
  • [1] Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals
    Attanoos, RL
    Thomas, DH
    Gibbs, AR
    [J]. HISTOPATHOLOGY, 2003, 43 (04) : 387 - 392
  • [2] Chua TC, 2009, CAN J SURG, V52, P59
  • [3] Germline BAP1 mutations and tumor susceptibility
    Goldstein, Alisa M.
    [J]. NATURE GENETICS, 2011, 43 (10) : 925 - 926
  • [4] Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
    Harbour, J. William
    Onken, Michael D.
    Roberson, Elisha D. O.
    Duan, Shenghui
    Cao, Li
    Worley, Lori A.
    Council, M. Laurin
    Matatall, Katie A.
    Helms, Cynthia
    Bowcock, Anne M.
    [J]. SCIENCE, 2010, 330 (6009) : 1410 - 1413
  • [5] Hayashi Y, 1989, Nihon Naika Gakkai Zasshi, V78, P1611
  • [6] Peritoneal Mesothelioma
    Hesdorffer, Mary E.
    Chabot, John
    DeRosa, Carolyn
    Taub, Robert
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2008, 9 (2-3) : 180 - 190
  • [7] Ocular melanoma - A review and the relationship to cutaneous melanoma
    Hurst, EA
    Harbour, JW
    Cornelius, LA
    [J]. ARCHIVES OF DERMATOLOGY, 2003, 139 (08) : 1067 - 1073
  • [8] Malignant peritoneal mesothelioma: a multicenter study on 81 cases
    Manzini, V. de Pangher
    Recchia, L.
    Cafferata, M.
    Porta, C.
    Siena, S.
    Giannetta, L.
    Morelli, F.
    Oniga, F.
    Bearz, A.
    Torri, V.
    Cinquini, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (02) : 348 - 353
  • [9] Margo Curtis E, 2004, Cancer Control, V11, P304
  • [10] Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005
    Moolgavkar, Suresh H.
    Meza, Rafael
    Turim, Jay
    [J]. CANCER CAUSES & CONTROL, 2009, 20 (06) : 935 - 944